← EASTMAN CHEMICAL CO
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $9.0b |
$9.5b
+6.01%
|
$10.2b
+6.30%
|
$9.3b
-8.65%
|
$8.5b
-8.63%
|
$10.5b
+23.64%
|
$10.6b
+0.99%
|
$9.2b
-12.95%
|
$9.4b
+1.87%
|
$8.8b
-6.71%
|
$8.9b
+1.29%
|
|
| Cost of Revenue | $6.7b |
$7.1b
+6.56%
|
$7.7b
+8.13%
|
$7.0b
-8.25%
|
$6.5b
-7.69%
|
$8.0b
+22.75%
|
$8.4b
+5.86%
|
$7.1b
-15.33%
|
$7.1b
-0.80%
|
$6.9b
-2.59%
|
$7.1b
+2.82%
|
|
| Gross Profit | $2.4b |
$2.5b
+4.43%
|
$2.5b
+1.02%
|
$2.2b
-9.88%
|
$2.0b
-11.59%
|
$2.5b
+26.58%
|
$2.1b
-14.52%
|
$2.1b
-3.56%
|
$2.3b
+11.11%
|
$1.8b
-19.48%
|
$1.8b
-4.45%
|
|
| Interest Income (Expense), Net | ($255.0m) |
($241.0m)
+5.49%
|
($235.0m)
+2.49%
|
($218.0m)
+7.23%
|
($210.0m)
+3.67%
|
($198.0m)
+5.71%
|
($182.0m)
+8.08%
|
($215.0m)
-18.13%
|
($200.0m)
+6.98%
|
($208.0m)
-4.00%
|
$8.0m
+103.85%
|
|
| Research and Development Expense | $219.0m | $215.0m | $235.0m | $234.0m | $226.0m | $254.0m | $264.0m | $239.0m | $250.0m | $255.0m | $246.0m | |
| Selling, General and Administrative Expense | $703.0m | $699.0m | $721.0m | $691.0m | $654.0m | $795.0m | $726.0m | $727.0m | $736.0m | $658.0m | $627.0m | |
| Amortization of Intangible Assets | $166.0m | $164.0m | $164.0m | $160.0m | $128.0m | $108.0m | $87.0m | $86.0m | $82.0m | $79.0m | — | |
| Operating Income (Loss) | $1.4b |
$1.5b
+10.77%
|
$1.3b
-14.49%
|
$902.0m
-31.15%
|
$530.0m
-41.24%
|
$1.1b
+104.15%
|
$977.0m
-9.70%
|
$1.1b
+11.26%
|
$1.1b
-0.83%
|
$568.0m
-47.31%
|
$889.0m
+56.51%
|
|
| Foreign Currency Transaction Gain (Loss), before Tax | ($27.0m) | ($5.0m) | ($12.0m) | ($9.0m) | ($16.0m) | ($10.0m) | ($16.0m) | ($11.0m) | ($11.0m) | ($9.0m) | — | |
| Gain (Loss) on Investments | $15.0m | $14.0m | $17.0m | $10.0m | $15.0m | $16.0m | $19.0m | $10.0m | $0 | ($1.0m) | — | |
| Other Nonoperating Income (Expense) | $1.0m | ($5.0m) | ($4.0m) | ($4.0m) | ($7.0m) | $11.0m | $3.0m | ($37.0m) | ($36.0m) | ($74.0m) | — | |
| Nonoperating Income (Expense) | $6.0m | ($2.0m) | $53.0m | ($3.0m) | ($8.0m) | $17.0m | $6.0m | ($38.0m) | ($47.0m) | ($84.0m) | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $422.0m | $654.0m | $718.0m | $454.0m | $164.0m | $645.0m | $205.0m | $357.0m | $147.0m | ($24.0m) | $538.0m | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $1.0b | $1.3b | $1.3b | $902.0m | $530.0m | $1.1b | $977.0m | $1.1b | $1.1b | $568.0m | $538.0m | |
| Income Tax Expense (Benefit) | $190.0m | ($99.0m) | $226.0m | $140.0m | $41.0m | $215.0m | $181.0m | $191.0m | $170.0m | $93.0m | $95.0m | |
| Net Income (Loss) Attributable to Parent | $854.0m |
$1.4b
+62.06%
|
$1.1b
-21.97%
|
$759.0m
-29.72%
|
$478.0m
-37.02%
|
$857.0m
+79.29%
|
$793.0m
-7.47%
|
$894.0m
+12.74%
|
$905.0m
+1.23%
|
$474.0m
-47.62%
|
$442.0m
-6.75%
|
|
| Net Income (Loss) Attributable to Noncontrolling Interest | $5.0m | $4.0m | $4.0m | $3.0m | $11.0m | $10.0m | $3.0m | $2.0m | $3.0m | $1.0m | $442.0m | |
| Earnings Per Share, Basic | $5.80 | $9.56 | $7.65 | $5.52 | $3.53 | $6.35 | $6.42 | $7.54 | $7.75 | $4.14 | $3.88 | |
| Earnings Per Share, Diluted | $5.75 | $9.47 | $7.56 | $5.48 | $3.50 | $6.25 | $6.35 | $7.49 | $7.67 | $4.10 | $3.84 | |
| Income (Loss) from Continuing Operations, Per Basic Share | $6 | $10 | $8 | $6 | $4 | $6 | $6 | $8 | $8 | $4 | — | |
| Income (Loss) from Continuing Operations, Per Diluted Share | $6 | $9 | $8 | $5 | $4 | $6 | $6 | $7 | $8 | $4 | — | |
| Common Stock, Dividends, Per Share, Declared | $1.89 | $2.09 | $2.30 | $2.52 | $2.67 | $2.83 | $3.07 | $3.18 | $3.26 | $3.33 | — | |
| Weighted Average Number of Shares Outstanding, Basic | 147.3m | 144.8m | 141.2m | 137.4m | 135.5m | 134.9m | 123.5m | 118.6m | 116.7m | 114.7m | 114.2m | |
| Weighted Average Number of Shares Outstanding, Diluted | 148.4m | 146.1m | 142.9m | 138.5m | 136.5m | 137.1m | 124.9m | 119.4m | 117.9m | 115.6m | 115.0m | |
| Additional Financial Items | ||||||||||||
| Goodwill, Impairment Loss | — | — | $38.0m | $45.0m | — | — | — | — | — | — | $33.0m | |
| Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax | $0 | $7.0m | $22.0m | $20.0m | $34.0m | $66.0m | $53.0m | $27.0m | $18.0m | $44.0m | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | $854.0m | $1.4b | $36.0m | $11.0m | $59.0m | $91.0m | $23.0m | $114.0m | $5.0m | $154.0m | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $859.0m | $4.0m | $4.0m | $3.0m | $11.0m | $10.0m | $3.0m | $2.0m | $3.0m | $1.0m | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | $0 | $72.0m | $36.0m | $11.0m | $59.0m | $91.0m | $23.0m | $114.0m | $5.0m | $154.0m | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.